[
  {
    "headline": "Starpharma Announces a Collaboration and License Agreement with Genentech",
    "summary": null,
    "source_url": "https://finance.yahoo.com/news/starpharma-announces-collaboration-license-agreement-113000026.html",
    "published": "09/22/2025, 11:30 AM, +0000 UTC",
    "source_name": "Yahoo Finance",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 1,
      "title": "Starpharma Announces a Collaboration and License Agreement with Genentech",
      "source": {
        "name": "Yahoo Finance",
        "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://finance.yahoo.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://finance.yahoo.com/news/starpharma-announces-collaboration-license-agreement-113000026.html",
      "thumbnail": "https://media.zenfs.com/en/globenewswire.com/2fee043d98a62978204abb620bce0bad",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNUVWall6YWpSU05UQlNlblYwVFJET0F4aVlCU2dLTWdhSmdZNUdMZ1k",
      "date": "09/22/2025, 11:30 AM, +0000 UTC"
    }
  },
  {
    "headline": "Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025",
    "summary": null,
    "source_url": "https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025",
    "published": "09/24/2025, 10:55 AM, +0000 UTC",
    "source_name": "BioSpace",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 2,
      "title": "Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025",
      "source": {
        "name": "BioSpace",
        "icon": "https://encrypted-tbn0.gstatic.com/faviconV2?url=https://www.biospace.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025",
      "thumbnail": "https://mms.businesswire.com/media/20250923346934/en/1138268/5/GENE_LOCKUP_Primary_FullColor_RGB_square.jpg",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNVBOMWhEVWkxU2VtZGpSMlJSVFJDcUJCaXFCQ2dLTWdZQmtKU2xOQWM",
      "date": "09/24/2025, 10:55 AM, +0000 UTC"
    }
  },
  {
    "headline": "Genentech to file for oral SERD approval on Phase III breast cancer win",
    "summary": null,
    "source_url": "https://www.clinicaltrialsarena.com/news/genentech-to-file-for-oral-serd-approval-on-phase-iii-breast-cancer-win/",
    "published": "09/22/2025, 10:33 AM, +0000 UTC",
    "source_name": "Clinical Trials Arena",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 3,
      "title": "Genentech to file for oral SERD approval on Phase III breast cancer win",
      "source": {
        "name": "Clinical Trials Arena",
        "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://www.clinicaltrialsarena.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
        "authors": [
          "Abigail Beaney"
        ]
      },
      "link": "https://www.clinicaltrialsarena.com/news/genentech-to-file-for-oral-serd-approval-on-phase-iii-breast-cancer-win/",
      "thumbnail": "https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2025/09/Breast-cancer-2-1-430x241.png",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXVNa3hEY2xBd1JHVXhWR0Z0VFJEeEFSaXVBeWdLTWdZUlFwWnRvUWc",
      "date": "09/22/2025, 10:33 AM, +0000 UTC"
    }
  },
  {
    "headline": "Genentech names next marketing chief as Erica Taylor takes on new role at Roche",
    "summary": null,
    "source_url": "https://www.fiercepharma.com/marketing/genentech-names-next-marketing-chief-erica-taylor-takes-new-role-roche",
    "published": "09/18/2025, 05:58 PM, +0000 UTC",
    "source_name": "Fierce Pharma",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 4,
      "title": "Genentech names next marketing chief as Erica Taylor takes on new role at Roche",
      "source": {
        "name": "Fierce Pharma",
        "icon": "https://encrypted-tbn0.gstatic.com/faviconV2?url=https://www.fiercepharma.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
        "authors": [
          "Andrea Park"
        ]
      },
      "link": "https://www.fiercepharma.com/marketing/genentech-names-next-marketing-chief-erica-taylor-takes-new-role-roche",
      "thumbnail": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Genentech.jpg?VersionId=msYeK7Bb99nNffjl1V.e3.YxtqIits5K",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXFhbVJwV0MxTVltRnVOV3g2VFJEWUFSaUFBeWdLTWdhTk1hQUhIUW8",
      "date": "09/18/2025, 05:58 PM, +0000 UTC"
    }
  },
  {
    "headline": "Genentech $569M deal lifts Starpharma stock 73%",
    "summary": null,
    "source_url": "https://www.bioworld.com/articles/724559-genentech-569m-deal-lifts-starpharma-stock-73",
    "published": "09/23/2025, 03:00 PM, +0000 UTC",
    "source_name": "BioWorld MedTech",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 5,
      "title": "Genentech $569M deal lifts Starpharma stock 73%",
      "source": {
        "name": "BioWorld MedTech",
        "icon": "https://encrypted-tbn3.gstatic.com/faviconV2?url=https://www.bioworld.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
        "authors": [
          "Tamra Sami"
        ]
      },
      "link": "https://www.bioworld.com/articles/724559-genentech-569m-deal-lifts-starpharma-stock-73",
      "thumbnail": "https://www.bioworld.com/ext/resources/Stock-images/Money/Stock-chart-upward-arrow.webp?t=1623701362",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iJ0NnNXlNV3gzUkhSdFZpMHhTRGhyVFJEZ0F4aUFCU2dLTWdNQlZBZw",
      "date": "09/23/2025, 03:00 PM, +0000 UTC"
    }
  },
  {
    "headline": "Starpharma Enters Strategic Collaboration with Genentech",
    "summary": null,
    "source_url": "https://www.tipranks.com/news/company-announcements/starpharma-enters-strategic-collaboration-with-genentech",
    "published": "09/22/2025, 02:28 AM, +0000 UTC",
    "source_name": "TipRanks",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 6,
      "title": "Starpharma Enters Strategic Collaboration with Genentech",
      "source": {
        "name": "TipRanks",
        "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://www.tipranks.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://www.tipranks.com/news/company-announcements/starpharma-enters-strategic-collaboration-with-genentech",
      "thumbnail": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2051377127-750x406.jpg",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNUhRM05KY1Zab1MxZFJkMUY0VFJDV0F4anVCU2dLTWdZQkFLaXhrQXc",
      "date": "09/22/2025, 02:28 AM, +0000 UTC"
    }
  },
  {
    "headline": "EQUITABLE CARE",
    "summary": null,
    "source_url": "https://www.gene.com/patients/equitable-care",
    "published": "06/05/2025, 11:39 PM, +0000 UTC",
    "source_name": "Genentech",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 7,
      "title": "EQUITABLE CARE",
      "source": {
        "name": "Genentech",
        "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://www.gene.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://www.gene.com/patients/equitable-care",
      "thumbnail": "https://www.gene.com/assets/content/block_column/block_column_item_image/generated_health-equity-image-1-V3-large.jpg?w=1280&h=720&fit=crop",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNW9ORVUxTjBzMmRUaFhZbWR3VFJDM0FSaVVBaWdCTWdZQlFKRExKQWM",
      "date": "06/05/2025, 11:39 PM, +0000 UTC"
    }
  },
  {
    "headline": "Genentech scraps $2B deal with cell therapy biotech",
    "summary": null,
    "source_url": "https://www.fiercebiotech.com/biotech/genentechs-summer-struggle-continues-scrapped-2b-cell-therapy-deal",
    "published": "08/18/2025, 07:00 AM, +0000 UTC",
    "source_name": "Fierce Biotech",
    "fetched": "2025-09-24T14:43:19.415284",
    "provenance": {
      "position": 8,
      "title": "Genentech scraps $2B deal with cell therapy biotech",
      "source": {
        "name": "Fierce Biotech",
        "icon": "https://encrypted-tbn0.gstatic.com/faviconV2?url=https://www.fiercebiotech.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
        "authors": [
          "Darren Incorvaia"
        ]
      },
      "link": "https://www.fiercebiotech.com/biotech/genentechs-summer-struggle-continues-scrapped-2b-cell-therapy-deal",
      "thumbnail": "https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2215262488.jpg?VersionId=4kAa7x6UkPoh5HvzoUq7zLI0JiWxuIUF",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iMkNnNXZRWEJwUldoWFZtMUZjRTk0VFJEWUFSaUFBeWdLTWdzQkFJeXBqT1ZMb1h1dWVn",
      "date": "08/18/2025, 07:00 AM, +0000 UTC"
    }
  }
]